Wuhan Hiteck Biological Co., Ltd. logo

Wuhan Hiteck Biological Co., Ltd. (300683)

Market Closed
11 Aug, 06:57
XSHE XSHE
¥
30. 65
+1.48
+5.0737%
¥
3.92B Market Cap
- P/E Ratio
0.13% Div Yield
15.05M Volume
- Eps
¥ 29.17
Previous Close
Add Transaction
Day Range
28.52 31.22
Year Range
22.58 61.76
Want to track 300683 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

300683 closed today higher at ¥30.65, an increase of 5.0737% from yesterday's close, completing a monthly increase of 22.3553% or ¥5.6. Over the past 12 months, 300683 stock gained 11.2119%.
300683 is not paying dividends to its shareholders.
The last earnings report, released on May 16, 2025, missed the consensus estimates by -0.1064%. On average, the company has fell short of earnings expectations by -0.1164%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on one exchange.

300683 Chart

People also search for

Dr Corp Ltd.
¥ 23.35
-2.4237%
Sunvim Group Co., Ltd.
¥ 11.72
-3.3003%
Tibet Gaozheng Explosive Co., Ltd.
¥ 58.61
-1.6281%
Innovative Medical Management Co., Ltd.
¥ 21.24
-3.1022%
Henan Liliang Diamond Co., Ltd.
¥ 59.21
-1.366%

Wuhan Hiteck Biological Co., Ltd. (300683) FAQ

What is the stock price today?

The current price is ¥30.65.

On which exchange is it traded?

Wuhan Hiteck Biological Co., Ltd. is listed on XSHE.

What is its stock symbol?

The ticker symbol is 300683.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.13%.

What is its market cap?

As of today, the market cap is 3.92B.

Has Wuhan Hiteck Biological Co., Ltd. ever had a stock split?

No, there has never been a stock split.

Wuhan Hiteck Biological Co., Ltd. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Ms. Wen Xian CEO
XSHE Exchange
CNE1000034C5 ISIN
CN Country
1,309 Employees
9 Jan 2025 Last Dividend
- Last Split
- IPO Date

Overview

Wuhan Hiteck Biological Pharma Co., Ltd is a pioneering biopharmaceutical entity concentrated on the development, manufacturing, and distribution of bioengineering products and freeze-dried powder injections within China. Founded in 1992, the company has established a formidable presence in the biopharmaceutical sector, driven by its commitment to innovation and quality in addressing complex health challenges. Its comprehensive portfolio spans across various therapeutic areas, notably in the nervous system, oncology, and infectious diseases, showcasing its versatility and dedication to advancing healthcare.

Products and Services

  • Anewway: A mouse nerve growth factor intended for injection, utilized as a regenerative therapy for nerve damage.
  • Omeprazole Sodium for Injection: Offers an alternative treatment solution for duodenal ulcer, gastric ulcer, reflux esophagitis, and Zollinger-Ellison syndrome.
  • Adenosine Cyclophosphate for Injection: Applied in the treatment of angina pectoris, myocardial infarction, myocarditis, and cardiogenic shock to improve cardiac outcomes.
  • Aciclovir Dispersible Tablets: Prescribed for the management of genital herpes virus infection, herpes zoster, and immune deficiency chickenpox, offering a broad antiviral coverage.
  • Indometacin and Furazolidone Suppositories: A targeted remedy for internal and external hemorrhoids, anal swelling, fistula, and other anorectal diseases, providing relief and healing.
  • Tinidazole Suppositories: Effective against trichomonas vaginitis and bacterial vaginosis, these suppositories aim to restore vaginal health and microbiome balance.
  • Nimodipine Sustained Release Tablets: Designed for the management of ischemic cerebrovascular disease, migraine, and cerebral vasospasm, enhancing cerebral blood flow.
  • Trimetazidine Dihydrochloride Tablets: Utilized in the treatment of stable angina, these tablets work by optimizing cardiac metabolism.
  • Azithromycin Granules: Aimed at the treatment of acute pharyngitis, tonsillitis, and bronchitis, this antibiotic addresses a range of bacterial respiratory infections.
  • Nucleic Acid Detection and Diagnostic Kits: Including products for measles and rubella virus detection, bacterial vaginosis rapid test kits, and a comprehensive range for the identification of various viral and bacterial infections. This category is vital for early and accurate disease diagnosis and management.
  • Lopinavir and Ritonavir APIs: Active pharmaceutical ingredients (APIs) for the production of antiretroviral medications used in the treatment of HIV/AIDS, demonstrating the company's capacity in contributing to global health crises.
  • Intermediates: The company also specializes in the provision of intermediates that are critical in the synthesis of complex molecules, further supporting various pharmaceutical applications.

Contact Information

Address: HITECK science and Technology Park, Wuhan, China, 430056
Phone: 86 27 8489 1666